v3.26.1
OPERATING SEGMENTS (Details) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Revenue $ 618,676 $ 281,318 $ 1,694,482 $ 425,327
General and administrative 364,539 1,129,360 1,216,444 2,089,773
Depreciation and amortization     25,450 26,478
Segment net income (loss) from operations (227,939) $ (814,192) (827,961) $ (1,718,272)
CODM [Member]        
Revenue 618,676   1,694,482  
Cost of revenues - product sales 466,004   1,256,774  
Cost of revenues - rent 7,500   23,775  
General and administrative 364,539   1,216,444  
Depreciation and amortization 8,572   25,450  
Segment net income (loss) from operations (227,939)   (827,961)  
CODM [Member] | Pharmaceutical Products Distribution [Member]        
Revenue 596,176   1,626,982  
Cost of revenues - product sales 466,004   1,256,774  
Cost of revenues - rent 0   0  
General and administrative 356,414   1,192,069  
Depreciation and amortization 6,124   18,373  
Segment net income (loss) from operations (232,366)   (840,234)  
CODM [Member] | Real Estate Development [Member]        
Revenue 22,500   67,500  
Cost of revenues - product sales 0   0  
Cost of revenues - rent 7,500   23,775  
General and administrative 8,125   24,375  
Depreciation and amortization 2,448   7,077  
Segment net income (loss) from operations $ 4,427   $ 12,273